Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles (NDC 0378-1811-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

D-0128-2025

November 18, 2024

Class II

Product summary

Firm
Viatris Inc
Event
Event 95768
Status
Ongoing
Classification
Class II
Quantity
35,883 bottles
Official record key
drug-enforcement:D-0128-2025

Official wording

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained

Code information: Lot #: a) 8171623, Exp. Date Feb 2025; 8164486, Exp. Date Nov 2024 b)3205462, Exp. Date Aug 2025; 3192428, Exp. Date Feb 2025; 3184096, Exp. Date Nov 2024

Distribution pattern: Nationwide within the United States and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent